AbbVie Maintains Xeljanz Safety Concerns Don’t Spill Over To Rinvoq

 
• By Joseph Haas
  
4th quarter computer key on key board
AbbVie's Q4 revenues came in strong despite some pandemic impact on the cancer franchise
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Earnings

More from Business